Table 5.
HR (95 % CI) | P | |
---|---|---|
eGFRa | 0.42(0.32-0.56) | <0.001 |
Proteinuriab | 2.27(1.70-3.02) | <0.001 |
Anemia | 4.18(2.10-8.33) | <0.001 |
Hyperuricemia | 2.31(1.08-4.93) | 0.03 |
TAIFc | 1.83(1.48-2.25) | <0.001 |
Global glomerulosclerosisc | 1.44(1.23-1.70) | <0.001 |
Segmental glomerulosclerosisc | 2.02(1.31-3.12) | 0.001 |
Presence of MN | 5.51(2.27-13.33) | <0.001 |
aper 10 ml/min/1.73 m2 increase; bper 1 g/24 h increase; cper 10 % increase
MN, malignant nephrosclerosis; TAIF, tubular atrophy/interstitial fibrosis; HR, hazard ratio; CI, confidence interval